Home » EMA to Wait for More Experience Before Issuing Guidance on Companion Diagnostics
EMA to Wait for More Experience Before Issuing Guidance on Companion Diagnostics
September 10, 2012
Known for its relatively relaxed regulation of companion diagnostics (CDx), guidance from the European Medicines Agency (EMA) is not expected until the agency gains more experience with these drug-device combinations, an expert says.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor